Therefore, our result with BTLA polymorphisms, if confirmed on a much larger cohort of smoking and never-smoking patients and controls of both sexes separately, may add a new element to molecular and immunological differences between women and men suffering from lung cancer, depending on their smoking status. The gene discussed is BTLA; the disease is lung carcinoma.